Trial Details

COMPLETED
Basic Information
Clinical ID c209
Identifier NCT06961435
Trial Title An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Colitis, Ulcerative
Interventions BIOLOGICAL: Vedolizumab
Participant Information
Sponsor Second Affiliated Hospital of Wenzhou Medical University
City Zhejiang
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2019-01-01
Primary Completion Date 2025-02-28
Completion Date 2025-02-28